Newron Pharmaceuticals is based in Milan, Italy. It has raised $160M in total funding. Backed by 3i, Atlas Venture, Apax.
Newron Pharmaceuticals funding overview
Newron Pharmaceuticals is based in Milan, Italy. Newron Pharmaceuticals has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include 3i, Atlas Venture, Apax, HBM BioVentures, HBM BioCapital, TVM Capital. 6 distinct backers are named across the disclosed rounds.
Newron Pharmaceuticals at a glance
Total raised
$160M
Headquarters
Milan, Italy
Notable investors
3i, Atlas Venture, Apax, HBM BioVentures, HBM BioCapital, TVM Capital
Frequently asked about Newron Pharmaceuticals funding
How much has Newron Pharmaceuticals raised?
Newron Pharmaceuticals has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Newron Pharmaceuticals?
3i, Atlas Venture, Apax, HBM BioVentures, HBM BioCapital, TVM Capital are named among the investors backing Newron Pharmaceuticals.
What was the latest Newron Pharmaceuticals funding round?
No round stage has been disclosed for Newron Pharmaceuticals.
Where is Newron Pharmaceuticals based?
Newron Pharmaceuticals is based in Milan, Italy.
Round data for Newron Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Milan and backer lists below.
